Mechanism of vasorelaxation of thoracic aorta caused by xanthone

European Journal of Pharmacology

Volumn 336, Issue 1, 1997, Pages 23-28

  Cheng, Yu Wen ^a   Kang, Jaw Jou ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ca2+ channel blocker; cAMP; cGMP; Norepinephrine; Thoracic aorta; Vasorelaxation

Indexed keywords

CYCLIC AMP; CYCLIC GMP; FORSKOLIN; INOSITOL 1,4,5 TRISPHOSPHATE; ISOBUTYLMETHYLXANTHINE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM; UNCLASSIFIED DRUG; VERAPAMIL; XANTHONE; XANTHONE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASODILATATION;

ANIMALS; AORTA, THORACIC; CALCIUM; CYCLIC AMP; INOSITOL PHOSPHATES; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS; XANTHENES; XANTHONES;

EID: 0030734799     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01224-7     Document Type: Article

References (30)

1. Adelstein R.S., Eisenberg E. Regulation and kinetics of the actin-myosine-ATP interaction. Ann. Rev. Biochem. 49:1980;921-956.
2. Bohr D.H. Vascular smooth muscle: Dual effect of calcium. Science. 139:1963;597-599.
3. Borridge M.J., Brownes C.P., Hanley M.R. Lithium amplifies agonist-dependent phosophoinositol response in brain and salivary glands. Biochem. J. 206:1982;586-587.
4. Ehrlich B.E., Watras J. Inositol 1,4,5-triphosphate activate channel from smooth muscle sarcoplasmic reticulum. Nature London. 336:1988;578-586.
5. Gruetter C.A., Barry B.K., Mcnamara D.B., Gruetter D.Y., Kadowitz P.J., Ignarro L.J. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carciogenic nitrosamine. J. Cycl. Nucleotide Res. 5:1979;211-224.
6. Hirata M., Kohse K.P., Chan C.H., Ikeb T., Murad F. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and culture bovine aortic smooth muscle cells. J. Biol. Chem. 256:1990;1268-1273.
7. Hudgins P.M., Weiss G.B. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J. Pharmacol. Exp. Ther. 159:1968;91-99.
8. Kamm K.E., Stull J.T. The function of myosin and myosin ligh chain kinase phosphorylation in smooth muscle. Ann. Rev. Pharmacol. Toxicol. 25:1985;593-620.
9. Kang J.J., Cheng Y.W., Ko F.N., Kuo M.L., Lin C.N., Teng C.M. Induction of calcium release from sarcoplasmic reticulum of skeletal muscle by xanthone and norathyriol. Br. J. Pharmacol. 118:1996;1736-1742.
10. 2+ in rabbit aortic smooth muscle by norepinephrine and potassium after exposure to lanthanium and low temperature J. Pharmacol. Exp. Ther. 211:1979;86-92.
11. Karaki H., Weiss G.B. Calcium channels in smooth muscle. Gastroenterology. 87:1984;960-970.
12. Karaki H., Sato K., Ozaki H., Murakami K. Effects of sodium nitroprusside on cytosolic calcium level in vascular smooth muscle. Eur. J. Pharmacol. 156:1988;259-266.
13. Kauffman R.F., Schenck K.W., Utterback B.G., Crowe V.G., Cohen M.L. In vitro vascular relaxation by new inotropic agents: Relationship to phosphodiesterase inhibition and cyclic nucleotides. J. Pharmacol. Exp. Ther. 242:1987;864-872.
14. 2+ uptake and cAMP in smooth muscle. Eur. J. Pharmacol. 61:1980;159-165.
15. Lin C.N., Chung C.H., Arisawa M., Shimizu M., Morita N. The constituents of Tripterospermum taiwanese statake var. alpinum satake and pharmacological activity of some xanthone derivatives. Shoyakugaku Zasshi. 38:1984;80.
16. Lowry D.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78:1986;1-5.
18. Murray P.K., Kotlikoff M.I. Receptor-activated calcium influx in human airway smooth muscle cells. J. Physiol. 435:1991;123-144.
19. 1-adrenoceptors in rat kidney mediated inositol phospholipid hydrolysis. Br. J. Pharmacol. 91:1987;367-376.
20. Nijkamp F.P., Engel F., Henricks P.A., Van Oosterhout A.J.M. Mechanism of β-adrenergic receptor regulation in lungs and its implications for physiological responses. Physiol. Rev. 72:1992;323-367.
21. Ousterhout J.M., Sperelakis N. Cyclic nucleotides depress action potentials in culture aortic smooth muscle cells. Eur. J. Pharmacol. 144:1987;7-14.
22. Scheid C.R., Honeyman T.W., Fay F.S. Mechanism of β-adrenergic relaxation of smooth muscle. Nature London. 277:1979;32-36.
23. Shankaranarayan D., Gopalakrishnan C., Kameswaran L. Pharmacological profile of Mangostin and its derivatives. Arch. Int. Pharmacodyn. 239:1979;257-269.
24. Silver P.J., Disalvo J. Adenosine 3′,5′-monophosphate mediated inhibition of myosin light chain phosphorylation in bovine aortic actomyosin. J. Biol. Chem. 254:1979;9951-9954.
25. Strandell M., Zakrisson S., Alsberg T., Weaserholm R.T., Winquist L., Rannug U. Chemical analysis and biological testing of a polar fraction of ambient air, diesel engine and gasoline particulate extracts. Environ. Health Persp. 102:1994;85-92.
26. 2+ uptake by highly purified sarcolemmal vesicles of vascular smooth muscle. Biochim. Biophys. Acta. 773:1984;83-90.
27. Torphy T.J., Undem B.J. Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax. 46:1991;512-523.
28. Twort C.H., van Breemen C. Human airway smooth muscle in cell culture: Control of the intracellular calcium store. Pulmonary Pharmacol. 2:1989;45-53.
29. 2+-uptake in rat cardiac sarcolemma vesicles. Biochem. Pharmacol. 32:1983;714-717.
30. Wang J.P., Raung S.L., Lin C.N., Teng C.M. Inhibitory effect of norathyriol, a xanthone from Tripterospermum lanceolatum, on cutaneous plasma extra vasation. Eur. J. Pharmacol. 251:1994;35-42.